Anebulo Pharmaceuticals, Inc.
ANEB
$1.05
-$0.02-1.87%
OTC PK
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 9.04M | 10.35M | 11.63M | 13.28M | 15.00M |
| Total Receivables | 56.80K | 9.80K | 73.20K | -- | 30.80K |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 175.40K | 170.80K | 261.40K | 528.00K | 366.30K |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 9.27M | 10.54M | 11.96M | 13.81M | 15.40M |
|
|
|||||
| Total Current Assets | 9.27M | 10.54M | 11.96M | 13.81M | 15.40M |
| Net Property, Plant & Equipment | -- | -- | -- | -- | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 148.20K | 165.70K | 183.10K | 200.50K | 445.70K |
| Total Assets | 9.42M | 10.70M | 12.15M | 14.01M | 15.84M |
|
|
|||||
| Total Accounts Payable | 554.90K | 607.50K | 224.20K | 427.60K | 319.50K |
| Total Accrued Expenses | 930.80K | 356.30K | 263.50K | 118.50K | 559.30K |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 1.49M | 963.80K | 487.70K | 546.00K | 878.80K |
|
|
|||||
| Total Current Liabilities | 1.49M | 963.80K | 487.70K | 546.00K | 878.80K |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 1.49M | 963.80K | 487.70K | 546.00K | 878.80K |
|
|
|||||
| Common Stock & APIC | 85.98M | 85.78M | 85.55M | 85.21M | 85.03M |
| Retained Earnings | -78.05M | -76.05M | -73.89M | -71.74M | -70.07M |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | 7.94M | 9.74M | 11.66M | 13.46M | 14.96M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 7.94M | 9.74M | 11.66M | 13.46M | 14.96M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 7.94M | 9.74M | 11.66M | 13.46M | 14.96M |
|
|
|||||